Dignio and AceAge Partner to Offer Karie Smart Pill Dispenser in Norway – Yahoo Finance

Spread the love

Oslo, Norway–(Newsfile Corp. – February 3, 2022) – Dignio AS, Norway's leading provider of digital remote care to Home Care services and Care Homes, announced today that it has integrated AceAge Inc. Karie – smart pill dispenser, into its Dignio Connected Care solution.
Karie integrated into Dignio Connected Care Platform
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/8089/112307_579b444ae486fb69_001full.jpg
Lars Dahle, Dignio Chief Executive Officer stated "Dignio's Connected Care platform connects Healthcare professionals and their patients using a web-based software and a user friendly patient app. The solution is integrated with a variety of measuring devices and now also the medication dispenser, Karie. With this dispenser, we can provide a secure and safe medication delivery that seamlessly integrates to ensure the patient remains independent, but never alone."
"Karie, by notifying and delivering a patient's medication dose in simple to use packets, promotes patient's wellness and independent lifestyle", contributed John Simmons, AceAge's Chief Executive Officer. "Karie also notifies Healthcare professionals, thru the Dignio Connected Care platform when missed doses occur, providing timely intervention that promotes medication adherence."
With the first customers already onboarded, over 200 Karie dispensers is now in the homes of patients all over Norway. Dignios Chief Medical officer, Meetali Kakad, explains why Karie results in positive outcomes. "Electronic medication dispensers, like Karie, ensure that patients get the right medication at the right time. Dispensers safely free up time that health care personnel can use for those in greatest need. Our experience shows that the Karie electronic medication dispenser offer patients greater peace of mind and freedom in everyday life. When combined with Dignio Connected Care patients receive the best possible assistance from health care personnel if they forget to take their medication."
Dignio introduced Karie – smart pill dispenser, in Norway in 2021, with plans to expand across other nordic countries, starting with Iceland.
-30-
About AceAge Inc.
AceAge, a healthcare technology company creating intuitive products to ease the aging process and improve health outcomes. AceAge's product, Karie, is a smart pill companion that delivers, reminds, connects and secures your medication to promote medication adherence. It is ideally suited for those needing to manage 3 or more medications simultaneously. Karie was designed to make medication management as simple as possible to ensure user independence and wellness, while providing caregivers with peace of mind.
Website: www.kariehealth.com
Facebook: Kariehealth
Twitter: @AceAgeKarie
LinkedIn: AceAge
For AceAge Inc. media inquiries, please contact:
Tony Karg
Director of Marketing
tony@aceage.com
416-702-1389
About Dignio
Dignio have ten years of experience with welfare technology, and is the market leader for remote care solutions in Norway. Dignio offers healthcare providers an optimal solution for delivering value-based care to patients in their own homes, empowering them to take charge of their own health with resulting of improved patient outcomes and a more sustainable healthcare system.
To view an overview of the Dignio platform, please click here: https://vimeo.com/641221811/b4b6bb4bed
Website: https://dignio.com/en/
LinkedIn: https://www.linkedin.com/company/dignio/

For Dignio Inc. media inquiries, please contact:
Name: Marianne Wilhelmsen
Title: Head of Marketing and Communications
Contact info: marianne@dignio.com +47 975 24 888
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/112307
When I first heard that Elon Musk had determined the identity of his successor, I breathed a sigh of relief. Musk's successor will run Tesla, not Twitter. Elon is sleeping at Twitter headquarters, and says he'll continue to do so until that company "is in a strong place."
Cathie Wood has built her career on holding contrarian views and her Ark Invest firm has been known to go against the grain. As such, 2022’s bear market has done little to change her stance. In fact, recently, Wood has been arguing that the Fed’s aggressive monetary stance in its ongoing efforts to curb soaring inflation is misguided. Highlighting deflationary signals, Wood says that unless it changes tack, the Fed’s actions could result in a repeat of the the Great Depression. “If the Fed does
As of 10:20 a.m. ET, shares of Chevron (NYSE: CVX) are trading 1.8% below Thursday's close, while oil industry bellwether ExxonMobil (NYSE: XOM) is down 2.1%, and independent oil producer Diamondback Energy (NASDAQ: FANG) leads the pack lower with a 5.6% loss. Valued at just 6.5 times earnings, and paying a rich 5.5% dividend yield, Diamondback's dividend alone seems nearly enough to justify the stock's price, even assuming zero growth in earnings.
Inovio is discontinuing development of its vaccine product candidates targeting Lassa Fever and Middle East Respiratory Syndrome, or MERS, the latest setback for the Montgomery County biotechnology company. Inovio said it agreed with its collaborator, the Coalition for Epidemic Preparedness Innovations (CEPI), to stop work on both experimental products, INO-4500 and INO-4700, following initial analyses of data from studies testing the effectiveness of each.
Yahoo Finance Live anchors discuss reports that Twitter headquarters will remain closed following Elon Musk’s ultimatum to employees.
The cryptocurrency exchange is sinking again after another analyst chimed in about its potential downsides.
(Bloomberg) — Elon Musk gave Twitter Inc. employees an ultimatum to either commit to the company’s new “hardcore” work environment or leave. Many more workers declined to sign on than he expected, potentially putting Twitter’s operations at risk, according to people familiar with the matter. Most Read from BloombergMusk’s ‘Hardcore’ Ultimatum Sparks Exodus, Leaving Twitter at RiskQatar Bans Alcohol Sales at World Cup Stadiums in Abrupt U-TurnThis Is the Memo Twitter Sent Telling Staff Offices W
Devon Energy (DVN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Mouse House has steadily grown its business by making major acquisitions, and now it's made another one in a very surprising way.
Zacks.com users have recently been watching Petrobras (PBR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Holiday sales are projected to reach as high as $960.4 billion, the National Retail Federation says.
Recently, Zacks.com users have been paying close attention to AT&T (T). This makes it worthwhile to examine what the stock has in store.
In today's video, Jose Najarro and Nick Rossolillo discuss Advanced Micro Devices (NASDAQ: AMD) and the numerous solutions AMD has announced for the data center market. Nick Rossolillo is excited about the vast opportunity accelerators provide AMD.
Fintech companies have revolutionized investing, investors have often been able to scoop up stocks for no trading commissions over the last few years. Investors who have a few dollars to invest can buy at least one whole share of each of these three affordable stocks for less than $50. Regardless of what's going on around the world, it's a safe bet (sadly health-wise) that cigarettes will always be consumed due to nicotine's addictive nature.
The FDA has granted Breakthrough Therapy designation to IVERIC bio Inc's (NASDAQ: ISEE) avacincaptad pegol (ACP, also known as Zimura), a novel investigational complement C5 inhibitor for geographic atrophy (GA) secondary to Age-Related Macular Degeneration (AMD). To date, ACP is the first and only investigational therapy to receive Breakthrough Therapy designation status for this indication, which was granted based on the 12-month pre-specified primary endpoint data in the GATHER1 and GATHER2 p
Coinbase has a lot of cash, but it's the company's stablecoin business that's a cash machine.
Tech company Shopify (NYSE: SHOP) has generated fantastic growth over the years. There's no doubt Shopify has achieved impressive results over the years providing entrepreneurs and business owners with various tools and services to run an e-commerce store. During the early stages of the pandemic, when people were losing their jobs or scrambling for ways to make some extra money, Shopify offered a way for its customers to profit from a hobby or trade.
The trust has historically traded for less than the value of the Bitcoin it holds, but the differential has widened as investors have soured on cryptocurrencies.
Warren Buffett is having a much better year than most S&P 500 investors. And he can thank a handful of stocks for that.
On Wednesday, Vox published a bombshell interview with former crypto exchange FTX CEO Sam Bankman-Fried, where the 30-year-old crypto trader all but revealed he had, in fact, co-mingled customer funds with those of his hedge fund, Alameda Research. This would be a problem on its own, as it violated FTX’s terms-of-service as well as likely falls afoul of wires or securities laws. Bankman-Fried’s crime, which “wasn’t quite lending [customer deposits] out” but something “messier,” “more organic” and “reasonable” than that, was compounded after a run on his exchange left up to one million FTX users without access to their funds.

source

Leave a Reply

%d bloggers like this: